RTTNews BiotechDoubao · 实盘不做把握 8/10不做原因:风险收益比不佳
北京时间·🕒 发布 13:58:15(美东 01:58)·⟳ 抓取 14:01:35 +3m20s·⚡ 决策 10-27 18:49:17 +4h47m·11.1 小时前
礼来宣布2026年第四季度每股1.73美元季度股息，12月10日派发
这是礼来按惯例进行的季度股息宣派（每股1.73美元，对应股息率约0.5%），属于市场完全预期内的常规资本返还，不含业绩、指引或基本面新增信息；对万亿市值巨头不构成可交易的价格催化，盘前几乎零反应(+0.07%)，风险收益不足，不做。
📄 原文RTTNews Biotech↗ 原文
Eli Lilly Declares Q4 2026 Dividend Of $1.73 Per Share
Eli Lilly and Company (LLY) said its board of directors has declared a fourth-quarter 2026 dividend of $1.73 per share…
不做 Eli Lilly and Company（LLY.US）
例行季度股息宣派（每股1.73美元、年化股息率约0.5%）为市场充分预期的程式化动作，无业绩/指引/特别股息等预期差，对约1.15万亿美元市值无短线弹性，盘前仅+0.07%；消息量级不足、风险收益不支持交易，等10/29三季报再评估。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
礼来例行宣布Q4每股1.73美元季度股息，程式化、低股息率、无预期差，对约1.15万亿美元市值无可交易弹性，盘前仅+0.07%，不做。
🔎 新鲜度:最早出现 2026-10-27 · 扩散 low · price-in 风险 high ↗
主要风险
- 10月29日三季报及管理层指引才是礼来下一个真正催化，本股息消息不应被当成提前布局理由。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-10-27 · 影响 weakens
未见特别股息、大幅上调或随附正面指引；该宣派为常规资本返还，无构成做多edge的新增事实。
检索:Eli Lilly Q4 2026 dividend special dividend increase guidance 原文 ↗
先例如何影响了这次决策
对本次决策的影响:确认不为此类程式化公告动用先例研究与行情工具，直接AVOID；真正节点为10/29三季报。
方向:巨型成熟药企的例行季度股息宣派/小幅上调历来不产生事件性超额收益，价格在除息日按股息机械调整，无方向性交易edge。
涨幅量级:无可靠对齐先例用于设定止盈幅度；本事件本身量级（年化股息率约0.5%）也不足以驱动任何短线波动。
形态:例行股息宣告普遍为无反应/见光不动，不具博奕价值。
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 407 ms
{"result": "search_processed_events:agent query=`eli lilly fourth-quarter 2026 dividend $1.73 per share | lly board declares q4 2026 dividend payable december 10 record november 13`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 68.6/72 小时、4108 条本臂决策(完整)，返回 8 条候选。\n• 10-26 10:46 UTC(北京 18:46) [ticker] 不做 LLY.US (rttnews_
原文全文
展开原文 · 1,451 字
Eli Lilly and Company (LLY) said its board of directors has declared a fourth-quarter 2026 dividend of $1.73 per share on its outstanding common stock.
The dividend is payable on December 10, 2026, to shareholders of record at the close of business on November 13, 2026.
Lilly is scheduled to report the third-quarter results on October 29, 2026.
For the second quarter of 2026, Lilly reported improved net income of $7.09 billion, or $7.94 per share, compared to $5.66 billion, or $6.29 per share, in the prior year.
The company reported revenue of $23.0 billion, up 48% year over year, driven primarily by strong demand for Mounjaro and Zepbound.
The company raised its full-year 2026 revenue guidance to $85.0 billion to $87.0 billion when it reported second-quarter 2026 results in August.
LLY has traded between $809.63 and $1,321.21 over the last year. The stock closed Monday's trade at $1279.14, up 0.45%.
In overnight trading, LLY is up another 0.07% at $1280.02.
For more biotech stock news, visit www.rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
October 16, 2026 16:06 ET Monthly consumer price inflation data and retail sales figures were the main news from the U.S. economy this week. In Europe, monthly GDP figures from the U.K. gained attention. External trade data from China was in focus in Asia. Elsewhere, the International Monetary Fund released its latest projections for the global economy.
The dividend is payable on December 10, 2026, to shareholders of record at the close of business on November 13, 2026.
Lilly is scheduled to report the third-quarter results on October 29, 2026.
For the second quarter of 2026, Lilly reported improved net income of $7.09 billion, or $7.94 per share, compared to $5.66 billion, or $6.29 per share, in the prior year.
The company reported revenue of $23.0 billion, up 48% year over year, driven primarily by strong demand for Mounjaro and Zepbound.
The company raised its full-year 2026 revenue guidance to $85.0 billion to $87.0 billion when it reported second-quarter 2026 results in August.
LLY has traded between $809.63 and $1,321.21 over the last year. The stock closed Monday's trade at $1279.14, up 0.45%.
In overnight trading, LLY is up another 0.07% at $1280.02.
For more biotech stock news, visit www.rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
October 16, 2026 16:06 ET Monthly consumer price inflation data and retail sales figures were the main news from the U.S. economy this week. In Europe, monthly GDP figures from the U.K. gained attention. External trade data from China was in focus in Asia. Elsewhere, the International Monetary Fund released its latest projections for the global economy.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
bc60c1d2c7· 2026-10-27 18:49 · doubao / doubao-seed-evolving-latest-version · 策略包b7b4acf827b8当前